STEPHANIE HEWITT: Open Payments
NPI 1588106736 · GRAPEVINE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 13 payments from 10 companies in 2025. Trend: 2023 $239 · 2024 $811 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $160 |
| Ferring Pharmaceuticals Inc. | 2 | $52 |
| Olympus America Inc. | 1 | $48 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Dendreon Pharmaceuticals LLC | 1 | $33 |
| Procept Biorobotics Corporation | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| CIVCO Medical Instruments | 1 | $17 |
| Myriad Genetic Laboratories, Inc. | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $13 |
Products named: ERLEADA, ADSTILADRIN, iTIND System, PROVENGE, KEYTRUDA, LYNPARZA, AQUABEAM ROBOTIC SYSTEM, GEMTESA.
Industry payments across TX — which companies pay providers there.
